Finance News – U.S.

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Tariffs Investors Ceo Stock Earnings Shares Stocks China Eqs Nasdaq Markets Investment Cet Trade Wall Street Nvidia Revenue Stock Market Class Action Securities Tesla Economy Bitcoin Sales Trade War Prices Inflation Us Company Apple Crypto Sp 500 Warren Buffett Guidance Federal Reserve Berkshire Hathaway Amazon Companies Shareholders Federal Securities Laws Pvr Ipo Walmart Interest Rates Profit Investor Trading Securities Laws Recession Monetary Policy Deal Afr Deposits Macroeconomic Uncertainty Crypto Company Call Options Asset Managers Brooklyn Nets Car Shoppers Fuller Smith Turner Plc

Filter by:

Copd × U.S. × Past year ×

MarketWatch Top Stories • May 30, 2025

Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure

The unsuccessful outcome of Regeneron’s advanced COPD therapy study led to a significant decline in its stock value, marking the company’s largest drop in over a decade on financia...

Read Full Article →